Differential (Click to cross reference) amantadine anticholinergic drugs antihistamines benserazide bradykinesia brain transplantation carbidopa cerebrospinal fluid coprolalia echolalia enzyme inhibition enzyme, defect genetic neurologic disorders Gilles de la Tourette syndrome headbanging hydroxyindole acetic acid 5(5HIAA) hydroxytryptophan L-5(L-5 HTP) L-dopa L-dopa, drug interactions with and side effects of L-dopa, potentiators of Lesch-Nyhan syndrome livedo reticularis madopar monoamine oxidase inhibitors myoclonic jerks myoclonus Parkinson disease Parkinson disease, on-off phenomena in Parkinson disease, surgical treatment of Parkinson disease, treatment of phenothiazine procyclidine pyridoxine reserpine and reserpine like drugs rigidity self-mutilation serotonin sinemet treatment of neurologic disorder tremor vitamin, multiple

Showing articles 0 to 9 of 9 Decreased Efficacy of Levodopa with Carbidopa in Parkinsonian Patients after Adrenal-to-Caudate Implants Neurol 40:845-846, Tsui,J.K.C.,et al, 1990 Response Variations in the Treatment of Parkinson's Disease Neurol 34:1507-1509, deJong,G.J.,et al, 1984 Increased Dosage of Carbidopa in Patients with Parkinson's Disease Receiving Low Doses of Levodopa Arch Neurol 37:146-149, Hoehn,M.M., 1980 Increased Ratio of Carbidopa to Levodopa in Treatment of Parkinson's Disease Arch Neurol 37:723-726, Tourtellotte,W.W.,et al, 1980 Sinemet-25/100 Medical Letter, 22:511980., , 1980 Comparative Effectiveness of Two Extracerebral DOPA Decarboxylase Inhibitors in Parkinson Disease Neurol 28:964-968, Lieberman,A.,et al, 1978 Purine Phosphoribosyltransferase in Gilles de la Tourette Syndrome NEJM 296:210, VanWoert,M.H.,et al, 1977 Long-term Therapy of Myoclonus & Other Neurologic Disorders with L-5-Hydroxytryptophan & Carbidopa NEJM 296:70, VanWoert,M.H.,et al, 1977 Drug Therapy of Parkinsonism NEJM 295:814, Bianchine,J.R., 1976 Showing articles 0 to 9 of 9